Post-approval studies (Phase 4)Ended earlyNCT03643159
What this trial is testing
A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Who this might be right for
SchizophreniaBipolar 1 DisorderMajor Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 2